Joel John

Joel John practices at Memorial Hospital Pembroke in Pembroke Pines, Florida, part of Memorial Healthcare System.

Joel John's NPI, 1336602804, was assigned on April 10, 2019. Joel John holds Florida license OS17762.

Joel John's primary practice is Memorial Hospital Pembroke, at 7800 Sheridan St, Pembroke Pines, FL 33024 in Broward County. The practice phone is (954) 962-9650.

Joel John's primary practice is Memorial Hospital Pembroke in Pembroke Pines, Florida, part of Memorial Healthcare System. Joel John is also affiliated with Memorial Hospital West. The medical group on file is Eastside Hospitalists. Dmand AI also links Joel John to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Joel John practices, 3 sites in all. Vendor and product names are available with a free account.

General practice is Joel John's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Joel John is licensed in Florida.

CMS data shows 380 Medicare services from Joel John across 6 procedure codes in 2024, for 144 Medicare patients. Medicare paid $29,031 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 144 Medicare patients who saw Joel John in 2026. The largest group is 65 to 74, with 50 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 3.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Joel John's median patient age at 65, with 53% women.

In 2026, Joel John wrote 408 Medicare Part D claims for 223 patients. 88% of them were for generic drugs. CMS names the drug for 140 of them, across 8 drugs with 11 or more claims each, at $1,049 in total drug cost. In 2023, CMS named 114 claims across 8 drugs.

Joel John accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to Joel John from 5 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $245.